330 related articles for article (PubMed ID: 26517480)
1. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
2. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Mitrovic N; Markovic A; Jordovic J; Katanic N; Barac A; Milosevic I
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):745-754. PubMed ID: 29299697
[TBL] [Abstract][Full Text] [Related]
3. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Lam SW; Bass SN; Neuner EA; Bauer SR
Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Nelson RL; Suda KJ; Evans CT
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
[TBL] [Abstract][Full Text] [Related]
7. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Wenisch C; Parschalk B; Hasenhündl M; Hirschl AM; Graninger W
Clin Infect Dis; 1996 May; 22(5):813-8. PubMed ID: 8722937
[TBL] [Abstract][Full Text] [Related]
9. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
[TBL] [Abstract][Full Text] [Related]
11. Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series.
Davido B; Leplay C; Bouchand F; Dinh A; Villart M; Le Quintrec JL; Teillet L; Salomon J; Michelon H
Clin Drug Investig; 2017 Jul; 37(7):699-703. PubMed ID: 28386820
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Louie T; Nord CE; Talbot GH; Wilcox M; Gerding DN; Buitrago M; Kracker H; Charef P; Cornely OA
Antimicrob Agents Chemother; 2015 Oct; 59(10):6266-73. PubMed ID: 26248357
[TBL] [Abstract][Full Text] [Related]
13. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
14. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
15. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection: a Serbian single-center experience.
Korac M; Milosevic I; Markovic M; Popovic N; Ilic M; Markovic A; Nikolic J; Jevtovic D
J Infect Dev Ctries; 2015 Feb; 9(2):136-40. PubMed ID: 25699487
[TBL] [Abstract][Full Text] [Related]
17. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
